Ann: Notice of Annual General Meeting/Proxy Form, page-2

At the coming AGM we are being asked, amongst other things, to vote for Resolution 4. I have copied the resolution below.

I for one will be voting against Resolution 4 and I think it's important that we, the shareholders in this forum, have an open discussion about this.

IMO Board members are already well remunerated for the work they do. But to add insult to injury now, after a disastrous performance of the SP (drop since April from $4.00 to just over 50c) this resolution would reward SH if he improves on that situation as per the formula set out in the resolution and Explanatory Memorandum. Really?

Now please, correct me if I am wrong, but the way I read it, if SH improves on this woeful situation (that has occurred under his watch as CEO) he can be rewarded notwithstanding that many, if not most of DLG's shareholders will continue to suffer in excess of a 50% loss in the value of their shares even after there is some recovery to the SP.

IMO we should not be considering a resolution like Resolution 4 until after there has already been a meaningful recovery to the SP so that we're not rewarding SH for what is essentially improving on the very low base he has brought us to and that many of us will continue to suffer while he is being rewarded.

IMO Resolution 4 should be deferred until the next AGM in November 2025.

..............................................................................................................................................................................

Resolution 4 - Issueof Performance Rights to Mr Simon Henry

To consider and, if thought fit, to pass, the following resolution as an ordinary resolution:

“That, for the purposes of Listing Rule 10.14 and for all other purposes, approval is given

for the Company to issue 710,000 Performance Rights to Chief Executive Officer Mr

Simon Henry (or his nominee(s)) under the Employee Incentive Securities Plan on the

terms and conditions set out in the Explanatory Statement.”

Further information refer to the Explanatory Memorandum on pages 10 to 16 of the Notice.